Denali Therapeutics Inc.
DNLI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001714899
In the last 90 days, Denali Therapeutics Inc. insiders filed 0 open-market purchases and 4 sales; 294 institutions reported holding it in 13F filings for Q2 2026, worth $4.00B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Denali Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- +13 vs. Q2 2022
- Shares held
- 92.4M
- −257.0K (−0.3%) vs. Q2 2022
- Total value
- $2.84B
- +$108.6M (+4.0%) vs. Q2 2022
- New holders
- 32
- 78 more added
- Sold out
- 19
- 56 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 294 | $4.00B |
| Q1 2026 | 269 | $2.82B |
| Q4 2025 | 250 | $2.50B |
| Q3 2025 | 240 | $1.97B |
| Q2 2025 | 231 | $1.93B |
| Q1 2025 | 222 | $1.85B |
| Q4 2024 | 224 | $2.61B |
| Q3 2024 | 217 | $3.69B |
| Q2 2024 | 203 | $2.88B |
| Q1 2024 | 211 | $2.51B |
| Q4 2023 | 209 | $2.47B |
| Q3 2023 | 195 | $2.24B |
| Q2 2023 | 203 | $3.18B |
| Q1 2023 | 202 | $2.49B |
| Q4 2022 | 199 | $2.94B |
| Q3 2022 | 200 | $2.84B |
| Q2 2022 | 188 | $2.73B |
| Q1 2022 | 190 | $2.79B |
| Q4 2021 | 213 | $3.80B |
| Q3 2021 | 214 | $4.28B |
| Q2 2021 | 210 | $6.32B |
| Q1 2021 | 218 | $4.60B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Denali Therapeutics Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −86,113−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −17,320−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −16,464−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,923−100.0% | Sold out |
| Utah Retirement Systems | 0 | $0 | 0.00% | −11,600−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −10,672−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −8,983−100.0% | Sold out |
| Bridgewater Associates, LP | 0 | $0 | 0.00% | −8,660−100.0% | Sold out |
| GAM Holding AG | 0 | $0 | 0.00% | −8,403−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,522−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −1,524−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Hoey Investments, Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Asset Management One Co.,Ltd. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Farmers & Merchants Investments Inc | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Private Capital Group, LLC | – | – | – | – | Not filed |